Print

Antigenics Inc. (New York) (AGEN) Buoyed by Brain-Cancer Study  
10/26/2009 8:03:13 AM

Bookmark and Share

Drug developer Antigenics Inc. said researchers at the University of California, San Francisco, reported positive results stemming from a study using its cancer therapy Oncophage to treat brain-cancer patients.

//-->